SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-671775
Filing Date
2016-08-04
Accepted
2016-08-04 16:06:53
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d201290d10q.htm 10-Q 554743
2 EX-31.1 d201290dex311.htm EX-31.1 5994
3 EX-31.2 d201290dex312.htm EX-31.2 6006
4 EX-32.1 d201290dex321.htm EX-32.1 3378
5 EX-32.2 d201290dex322.htm EX-32.2 3419
  Complete submission text file 0001193125-16-671775.txt   2623460

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20160630.xml EX-101.INS 422219
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20160630.xsd EX-101.SCH 29941
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20160630_cal.xml EX-101.CAL 46025
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20160630_def.xml EX-101.DEF 96605
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20160630_lab.xml EX-101.LAB 273565
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20160630_pre.xml EX-101.PRE 181688
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 161807427
SIC: 2834 Pharmaceutical Preparations